Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,335.30 -19.12 -0.12%
S&P 500 1,666.29 -1.18 -0.07%
Nasdaq 3,496.43 -2.53 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,806.89 -17.61 -0.62%
FTSE 100 6,756.47 +0.84 0.01%
DAX 8,419.36 -36.47 -0.43%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,366.40 -126.66 -0.54%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

AMGN:US

102.1800 USD 3.4500 3.27%

As of 20:10:00 ET on 05/20/2013.

Company Profile for Amgen Inc (AMGN)

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Contact Information

Amgen Inc

One Amgen Center Drive
Building 27
Thousand Oaks, CA 91320-1799
United States
Phone: 1-805-447-1000
Fax: 1-805-447-1010

Key Executives for Amgen Inc (AMGN)

Robert A Bradway "Bob"Chairman/President/CEOJonathan M PeacockExec VP/CFO
Anthony C Hooper "Tony"Exec VP:Commercial OpsMadhavan BalachandranExec VP:Operations
Sean E HarperExec VP:Rsch & DevBrian M McNameeSenior VP:Human Resources
David J ScottSenior VP/Secy/Gen CnslArvind SoodVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil